» Articles » PMID: 35327320

Characterisation of Severe Traumatic Brain Injury Severity from Fresh Cerebral Biopsy of Living Patients: An Immunohistochemical Study

Overview
Journal Biomedicines
Date 2022 Mar 25
PMID 35327320
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury (TBI) is an extremely complex disease and current systems classifying TBI as mild, moderate, and severe often fail to capture this complexity. Neuroimaging cannot resolve the cellular and molecular changes due to lack of resolution, and post-mortem tissue examination may not adequately represent acute disease. Therefore, we examined the cellular and molecular sequelae of TBI in fresh brain samples and related these to clinical outcomes. Brain biopsies, obtained shortly after injury from 25 living adult patients suffering severe TBI, underwent immunohistochemical analysis. There were no adverse events. Immunostaining revealed various qualitative cellular and biomolecular changes relating to neuronal injury, dendritic injury, neurovascular injury, and neuroinflammation, which we classified into 4 subgroups for each injury type using the newly devised Yip, Hasan and Uff (YHU) grading system. Based on the Glasgow Outcome Scale-Extended, a total YHU grade of ≤8 or ≥11 had a favourable and unfavourable outcome, respectively. Biomolecular changes observed in fresh brain samples enabled classification of this heterogeneous patient population into various injury severity categories based on the cellular and molecular pathophysiology according to the YHU grading system, which correlated with outcome. This is the first study investigating the acute biomolecular response to TBI.

Citing Articles

Omega-3 Fatty Acids and Traumatic Injury in the Adult and Immature Brain.

Valero-Hernandez E, Tremoleda J, Michael-Titus A Nutrients. 2024; 16(23).

PMID: 39683568 PMC: 11643940. DOI: 10.3390/nu16234175.


Neurotrauma-From Injury to Repair: Clinical Perspectives, Cellular Mechanisms and Promoting Regeneration of the Injured Brain and Spinal Cord.

Stevens A, Belli A, Ahmed Z Biomedicines. 2024; 12(3).

PMID: 38540256 PMC: 10968440. DOI: 10.3390/biomedicines12030643.


Serum amyloid P component accumulates and persists in neurones following traumatic brain injury.

Yip P, Liu Z, Hasan S, Pepys M, Uff C Open Biol. 2023; 13(12):230253.

PMID: 38052249 PMC: 10697800. DOI: 10.1098/rsob.230253.


Advances Research in Traumatic Encephalopathy.

Sriram S, Lucke-Wold B Biomedicines. 2022; 10(9).

PMID: 36140388 PMC: 9496579. DOI: 10.3390/biomedicines10092287.


Antioxidant Therapeutic Strategies in Neurodegenerative Diseases.

Moren C, deSouza R, Giraldo D, Uff C Int J Mol Sci. 2022; 23(16).

PMID: 36012599 PMC: 9409201. DOI: 10.3390/ijms23169328.


References
1.
Hasan S, Chari A, Ganau M, Uff C . Defining New Research Questions and Protocols in the Field of Traumatic Brain Injury through Public Engagement: Preliminary Results and Review of the Literature. Emerg Med Int. 2019; 2019:9101235. PMC: 6875310. DOI: 10.1155/2019/9101235. View

2.
Teasdale G, Jennett B . Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974; 2(7872):81-4. DOI: 10.1016/s0140-6736(74)91639-0. View

3.
Thau-Zuchman O, Ingram R, Harvey G, Cooke T, Palmas F, Pallier P . A Single Injection of Docosahexaenoic Acid Induces a Pro-Resolving Lipid Mediator Profile in the Injured Tissue and a Long-Lasting Reduction in Neurological Deficit after Traumatic Brain Injury in Mice. J Neurotrauma. 2019; 37(1):66-79. DOI: 10.1089/neu.2019.6420. View

4.
Wilson J, Pettigrew L, Teasdale G . Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998; 15(8):573-85. DOI: 10.1089/neu.1998.15.573. View

5.
Yip P, Wong L, Sears T, Yanez-Munoz R, McMahon S . Cortical overexpression of neuronal calcium sensor-1 induces functional plasticity in spinal cord following unilateral pyramidal tract injury in rat. PLoS Biol. 2010; 8(6):e1000399. PMC: 2889931. DOI: 10.1371/journal.pbio.1000399. View